226 related articles for article (PubMed ID: 15892300)
41. Neurofibrillary changes undergoing morphological and biochemical changes - How does tau with the profile shift of from four repeat to three repeat spread in Alzheimer brain?
Uchihara T
Neuropathology; 2020 Oct; 40(5):450-459. PubMed ID: 32698244
[TBL] [Abstract][Full Text] [Related]
42. Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy.
Paviour DC; Lees AJ; Josephs KA; Ozawa T; Ganguly M; Strand C; Godbolt A; Howard RS; Revesz T; Holton JL
Brain; 2004 Nov; 127(Pt 11):2441-51. PubMed ID: 15459024
[TBL] [Abstract][Full Text] [Related]
43. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
Wilhelmsen KC; Forman MS; Rosen HJ; Alving LI; Goldman J; Feiger J; Lee JV; Segall SK; Kramer JH; Lomen-Hoerth C; Rankin KP; Johnson J; Feiler HS; Weiner MW; Lee VM; Trojanowski JQ; Miller BL
Arch Neurol; 2004 Mar; 61(3):398-406. PubMed ID: 15023818
[TBL] [Abstract][Full Text] [Related]
44. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.
Saijo E; Ghetti B; Zanusso G; Oblak A; Furman JL; Diamond MI; Kraus A; Caughey B
Acta Neuropathol; 2017 May; 133(5):751-765. PubMed ID: 28293793
[TBL] [Abstract][Full Text] [Related]
45. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
[TBL] [Abstract][Full Text] [Related]
46. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia.
Zhukareva V; Vogelsberg-Ragaglia V; Van Deerlin VM; Bruce J; Shuck T; Grossman M; Clark CM; Arnold SE; Masliah E; Galasko D; Trojanowski JQ; Lee VM
Ann Neurol; 2001 Feb; 49(2):165-75. PubMed ID: 11220736
[TBL] [Abstract][Full Text] [Related]
47. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias.
Delacourte A
Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():75-9. PubMed ID: 10436346
[TBL] [Abstract][Full Text] [Related]
48. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
[TBL] [Abstract][Full Text] [Related]
49. Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.
Robinson JL; Yan N; Caswell C; Xie SX; Suh E; Van Deerlin VM; Gibbons G; Irwin DJ; Grossman M; Lee EB; Lee VM; Miller B; Trojanowski JQ
J Neuropathol Exp Neurol; 2020 Mar; 79(3):296-304. PubMed ID: 31999351
[TBL] [Abstract][Full Text] [Related]
50. Frontotemporal lobar degeneration--tau as a pied piper?
Tolnay M; Probst A
Neurogenetics; 2002 Oct; 4(2):63-75. PubMed ID: 12481984
[TBL] [Abstract][Full Text] [Related]
51. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
[TBL] [Abstract][Full Text] [Related]
52. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
Rademakers R; Baker M; Gass J; Adamson J; Huey ED; Momeni P; Spina S; Coppola G; Karydas AM; Stewart H; Johnson N; Hsiung GY; Kelley B; Kuntz K; Steinbart E; Wood EM; Yu CE; Josephs K; Sorenson E; Womack KB; Weintraub S; Pickering-Brown SM; Schofield PR; Brooks WS; Van Deerlin VM; Snowden J; Clark CM; Kertesz A; Boylan K; Ghetti B; Neary D; Schellenberg GD; Beach TG; Mesulam M; Mann D; Grafman J; Mackenzie IR; Feldman H; Bird T; Petersen R; Knopman D; Boeve B; Geschwind DH; Miller B; Wszolek Z; Lippa C; Bigio EH; Dickson D; Graff-Radford N; Hutton M
Lancet Neurol; 2007 Oct; 6(10):857-68. PubMed ID: 17826340
[TBL] [Abstract][Full Text] [Related]
53. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
54. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum.
Mackenzie IR; Feldman HH
J Neuropathol Exp Neurol; 2005 Aug; 64(8):730-9. PubMed ID: 16106222
[TBL] [Abstract][Full Text] [Related]
55. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
[TBL] [Abstract][Full Text] [Related]
56. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
[TBL] [Abstract][Full Text] [Related]
57. Specific detection of pathological three-repeat tau after pretreatment with potassium permanganate and oxalic acid in PSP/CBD brains.
Uchihara T; Nakamura A; Shibuya K; Yagishita S
Brain Pathol; 2011 Mar; 21(2):180-8. PubMed ID: 20825412
[TBL] [Abstract][Full Text] [Related]
58. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
[TBL] [Abstract][Full Text] [Related]
59. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
[TBL] [Abstract][Full Text] [Related]
60. Tau and alpha-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia.
Yancopoulou D; Xuereb JH; Crowther RA; Hodges JR; Spillantini MG
J Neuropathol Exp Neurol; 2005 Mar; 64(3):245-53. PubMed ID: 15804056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
